[Treatment of acute nonlymphoblastic leukemia in childhood: results of protocol ANLL-827 and ANLL-861 studies. Children's Cancer and Leukemia Study Group]. 1987

M Yanai, and Y Tsuji, and T Takeda, and T Oka, and M Yatabe, and A Kikuta, and Y Kaneko, and I Sekine, and T Matsushita, and J Utsumi

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D011241 Prednisone A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. Dehydrocortisone,delta-Cortisone,Apo-Prednisone,Cortan,Cortancyl,Cutason,Dacortin,Decortin,Decortisyl,Deltasone,Encorton,Encortone,Enkortolon,Kortancyl,Liquid Pred,Meticorten,Orasone,Panafcort,Panasol,Predni Tablinen,Prednidib,Predniment,Prednison Acsis,Prednison Galen,Prednison Hexal,Pronisone,Rectodelt,Sone,Sterapred,Ultracorten,Winpred,Acsis, Prednison
D012074 Remission Induction Therapeutic act or process that initiates a response to a complete or partial remission level. Induction of Remission,Induction, Remission,Inductions, Remission,Remission Inductions
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D003561 Cytarabine A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472) Ara-C,Arabinofuranosylcytosine,Arabinosylcytosine,Cytosine Arabinoside,Aracytidine,Aracytine,Cytarabine Hydrochloride,Cytonal,Cytosar,Cytosar-U,beta-Ara C,Ara C,Arabinoside, Cytosine,Cytosar U,beta Ara C
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute

Related Publications

M Yanai, and Y Tsuji, and T Takeda, and T Oka, and M Yatabe, and A Kikuta, and Y Kaneko, and I Sekine, and T Matsushita, and J Utsumi
July 1985, Gan no rinsho. Japan journal of cancer clinics,
M Yanai, and Y Tsuji, and T Takeda, and T Oka, and M Yatabe, and A Kikuta, and Y Kaneko, and I Sekine, and T Matsushita, and J Utsumi
August 1991, Acta paediatrica Japonica : Overseas edition,
M Yanai, and Y Tsuji, and T Takeda, and T Oka, and M Yatabe, and A Kikuta, and Y Kaneko, and I Sekine, and T Matsushita, and J Utsumi
January 1996, Medicinski pregled,
M Yanai, and Y Tsuji, and T Takeda, and T Oka, and M Yatabe, and A Kikuta, and Y Kaneko, and I Sekine, and T Matsushita, and J Utsumi
April 1995, [Rinsho ketsueki] The Japanese journal of clinical hematology,
M Yanai, and Y Tsuji, and T Takeda, and T Oka, and M Yatabe, and A Kikuta, and Y Kaneko, and I Sekine, and T Matsushita, and J Utsumi
January 1998, Anticancer research,
M Yanai, and Y Tsuji, and T Takeda, and T Oka, and M Yatabe, and A Kikuta, and Y Kaneko, and I Sekine, and T Matsushita, and J Utsumi
February 1993, [Rinsho ketsueki] The Japanese journal of clinical hematology,
M Yanai, and Y Tsuji, and T Takeda, and T Oka, and M Yatabe, and A Kikuta, and Y Kaneko, and I Sekine, and T Matsushita, and J Utsumi
November 1998, [Rinsho ketsueki] The Japanese journal of clinical hematology,
M Yanai, and Y Tsuji, and T Takeda, and T Oka, and M Yatabe, and A Kikuta, and Y Kaneko, and I Sekine, and T Matsushita, and J Utsumi
January 2004, The Turkish journal of pediatrics,
M Yanai, and Y Tsuji, and T Takeda, and T Oka, and M Yatabe, and A Kikuta, and Y Kaneko, and I Sekine, and T Matsushita, and J Utsumi
May 1985, Cancer,
M Yanai, and Y Tsuji, and T Takeda, and T Oka, and M Yatabe, and A Kikuta, and Y Kaneko, and I Sekine, and T Matsushita, and J Utsumi
January 1989, Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association,
Copied contents to your clipboard!